AAP
EBS icon

Arax Advisory Partners’s Emergent Biosolutions EBS Stock Holding History

Arax Advisory Partners’s Portfolio EBS Stock Details EBS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$1.2K Buy
145
+109
+303% +$1.13K ﹤0.01% 3249
2025
Q4 		$446 Sell
36
-2,609
-99% -$28K ﹤0.01% 3628
2025
Q3 		$23.3K Buy
+2,645
New +$20.6K ﹤0.01% 2198
2025
Q1 		– Sell
-472
Closed -$4.51K – 2780
2024
Q4 		$4.51K Sell
472
-1,335
-74% -$12.3K ﹤0.01% 1774
2024
Q3 		$15.1K Hold
1,807
– – ﹤0.01% 1212
2024
Q2 		$12.3K Buy
+1,807
New +$7.78K ﹤0.01% 1168

Other funds holding EBS

BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
PCM
Palisade Capital Management Fort Lee, New Jersey $3B AUM 14% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM